Endomeda - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 519,746 | 408,670 | 503,105 | 489,864 | 437,485 | 494,390 | 507,914 | 439,721 |
| Profit before tax | 115,249 | 73,717 | 171,288 | 130,334 | 88,051 | 128,704 | 119,151 | 69,183 |
| Net profit | 98,113 | 61,522 | 145,547 | 110,549 | 81,499 | 109,662 | 101,652 | 57,824 |
| Equity | 423,603 | 325,125 | 470,672 | 581,221 | 462,720 | 572,382 | 674,034 | 731,858 |
| Liabilities | 103,653 | 24,738 | 58,641 | 42,897 | 27,614 | 174,496 | 157,229 | 42,493 |
| Non-current assets | 148,465 | 126,107 | 107,712 | 90,937 | 123,991 | 98,698 | 76,856 | 55,707 |
| Current assets | 378,791 | 223,756 | 421,537 | 539,932 | 373,169 | 654,399 | 753,737 | 717,973 |
| Total assets | 527,256 | 349,863 | 529,249 | 630,869 | 497,160 | 753,097 | 830,593 | 773,680 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 35,792 | 31,002 | 61,249 |
| Social insurance contributions | - | - | - | - | - | 12,546 | 12,744 | 13,322 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +26.9% | -21.4% | +23.1% | -2.6% | -10.7% | +13.0% | +2.7% | -13.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 18.6% | 17.6% | 27.5% | 17.5% | 16.4% | 14.6% | 12.2% | 7.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 23.2% | 18.9% | 30.9% | 19.0% | 17.6% | 19.2% | 15.1% | 7.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 18.9% | 15.1% | 28.9% | 22.6% | 18.6% | 22.2% | 20.0% | 13.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 22.2% | 18.0% | 34.0% | 26.6% | 20.1% | 26.0% | 23.5% | 15.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0.2 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 68,538 | 51,084 | 62,888 | 69,158 | 72,914 | 83,558 | 84,652 | 85,107 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Endomeda - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-09-16 | 2025-09-16 | 196.51 |
| 2025-08-31 | 2025-09-02 | 119.37 |
| 2025-08-19 | 2025-08-29 | 119.37 |
| 2025-07-16 | 2025-07-31 | 53.42 |
Endomeda - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-20 | 2026-01-23 | 165.25 |
| 2026-01-16 | 2026-01-19 | 164.21 |
| 2025-11-20 | 2025-11-25 | 8.15 |
| 2025-06-19 | 2025-06-19 | 0.15 |
| 2025-05-29 | 2025-06-16 | 0.15 |
| 2025-04-28 | 2025-05-13 | 0.15 |
| 2025-04-04 | 2025-04-18 | 0.15 |
| 2025-04-03 | 2025-04-03 | 160.41 |
| 2025-03-28 | 2025-04-02 | 0.15 |
| 2025-03-20 | 2025-03-24 | 1.77 |
| 2025-02-28 | 2025-03-15 | 1.77 |
| 2025-02-19 | 2025-02-24 | 1.7 |
| 2025-02-18 | 2025-02-18 | 2.7 |
| 2025-02-12 | 2025-02-17 | 0.72 |
| 2025-02-04 | 2025-02-11 | 655.73 |
| 2025-02-02 | 2025-02-03 | 660.93 |
| 2025-01-31 | 2025-02-01 | 656.07 |
| 2025-01-30 | 2025-01-30 | 655.01 |
| 2025-01-17 | 2025-01-24 | 655.01 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Endomeda, UAB (code 135128174) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In financial year 2025, the company generated revenue of €439.7K and net profit of €57.8K, resulting in a profit margin of 13.2%. Performance weakened year on year, with revenue down 13.4% from 2024 and also below the 2023 level. Profit followed the same direction, falling from €109.7K in 2023 to €101.7K in 2024 and €57.8K in 2025. The balance sheet remained conservative, with total assets of €773.7K, equity of €731.9K and liabilities of €42.5K at the end of 2025. This corresponds to an equity ratio of 94.6% and a debt-to-equity ratio of 0.06. Asset turnover was 0.57x, while return on equity was 7.9% and return on assets 7.5%. Productivity indicators show revenue per employee of €87.9K and profit per employee of €11.6K.